Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes

Authors

  • Ali Rostami Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran.
  • Farzad Shidfar Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran.
  • Hamid Zolfaghari Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran.
  • Mitra Zarrati Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran.
  • Mohamad Ebrahim Khamseh Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran.
  • Neda Haghighat Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran.
Abstract:

  Background :Some results exist on fetuin-A as marker for vascular disease in type 2diabetes. We examined the relationship between serum fetuin-A with some factors, in patients with type 2 diabetes mellitus (T2DM).   Methods : From October 2012 to June 2013, a total of 131 T2DM patients were recruited and evaluated for various parameters including HOMA-IR, Apo-A1, Apo-B100, body fat percentage and waist circumference. Serum fetuin-A levels were measured by enzyme-linkedimmunosorbent assay (ELISA), and Serum glucose with a Cobas MIRA analyzer by enzymatic method. Apo-B100 and apo-A1 were measured by immunoturbidimetry with a Cobas MIRA analyzer. HOMA-IR was calculated by the following formula: [fasting insulin (uIU/mL) × fasting blood glucose (mmol/L)]/22.5.   Results : The mean levels of HOMA-IR were significantly increased progressively across fetuin-A tertiles (pfor trend=0.04) in women but not men. Fetuin-A had just a significant positive correlation withApo- A1(r=0.22, p=0.02).   Conclusion : This present study showed that levels of serum fetuin-A are significantly associated with insulin resistance in women with T2DM.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

relationship between serum levels of fetuin-a with apo-a1, apo-b100, body composition and insulin resistance in patients with type 2 diabetes

background :some results exist on fetuin-a as marker for vascular disease in type 2diabetes. we examined the relationship between serum fetuin-a with some factors, in patients with type 2 diabetes mellitus (t2dm).   methods : from october 2012 to june 2013, a total of 131 t2dm patients were recruited and evaluated for various parameters including homa-ir, apo-a1, apo-b100, body fat percentage a...

full text

The Relationship between Serum Levels of Irisin with Cardiometabolic Biomarkers in Patients with Type 2 Diabetes

Background: Diabetes and obesity are associated with an increased risk of cardiovascular disease. Irisin is a newly recognized peptidic myokine with anti-obesity and anti-diabetic properties. This study aims to investigate the relationship between serum irisin levels with cardiometabolic biomarkers in patients with type 2 diabetes mellitus (T2DM). Methods: In this comparative cross- sectional s...

full text

A Study on Apo B100/apo A-i Ratio in Uncontrolled Type 2 Diabetes Mellitus

Objectives: Dyslipidemia, a very common complication of diabetes mellitus (DM), is associated with life threatening complication like coronary artery disease (CAD). Apolipoprotein A-I and apo B100 are the protein components of high density lipoprotein (HDL-C) and low density lipoprotein (LDL-C) respectively. Apo B100/apo A-I ratio represents the balance between pro-atherogenic and antiatherogen...

full text

Serum resistin levels in patients with type 2 diabetes mellitus and its relationship with body composition.

OBJECTIVE To assess the relationships of resistin concentrations with body mass index (BMI), body fat mass, lean body mass, and body protein mass in patients with type 2 diabetes mellitus (DM). METHODS This cross-sectional study was conducted in the Department of Physiology, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia from April 2008 to March 2011. A total of 2...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 28  issue 1

pages  646- 652

publication date 2014-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023